ӯƱ

NEWS more +

  • Zai Lab Announces Acceptance of NDA Submission of Omadacycline in China by the NMPA

  • Zai Lab Announces First Patients Treated in Separate Phase 1b and Registrational Bridging Studies

  • Zai Lab Announces Pricing of Public Offering of American Depositary Shares

ӣƽ̨_  ˷ַͧ¼  pk10ַ  һŲƱ  ˷ͧ¼ַ  pc28  ٷͧ  ֱƱ  ǻ۲Ʊ  Ф